ArticleJournal of chemical biology2017

Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery-a structure-based approach.

Vishwanath Ramatenki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.